Sight Sciences Q2 Sales $12.5M, Up 258% YoY

Generated second quarter 2021 total revenue of $12.5 million, an increase of 258% compared to the prior year period, including; Surgical Glaucoma sales of $12.0 million, an increase
  • Generated second quarter 2021 total revenue of $12.5 million, an increase of 258% compared to the prior year period, including;
    • Surgical Glaucoma sales of $12.0 million, an increase of 263% compared to the prior year period
    • Dry Eye sales of $0.5 million, an increase of 169% compared to the prior year period
  • Expanded gross margin to 82% in the second quarter 2021 versus 40% in the prior year period
  • Completed an initial public offering in July raising approximately $253 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses
Total
0
Shares
Related Posts